Conditions: Carcinoma, Non Small Cell Lung
Allocation: NON_RANDOMIZED | Intervention model: 
Enrollment: 55
Healthy volunteers: no

Brief summary:
To assess the safety and efficacy of PF-00299804 in patients with advanced lung cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: PF-00299804
Intervention descriptions: intervention 1: Single arm (no comparator) study, oral once daily dosing, dose escalation (it is a phase 1/2 study) until disease progression, unacceptable toxicity or withdrawal of consent

Protocol document: